Compare KIDS & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KIDS | NPCE |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.2M | 432.3M |
| IPO Year | 2016 | 2021 |
| Metric | KIDS | NPCE |
|---|---|---|
| Price | $17.86 | $15.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $24.67 | $18.33 |
| AVG Volume (30 Days) | 147.4K | ★ 170.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | $98,049,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $14.07 | $0.90 |
| Revenue Next Year | $11.85 | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 37.95 | 25.13 |
| 52 Week Low | $14.91 | $7.56 |
| 52 Week High | $23.70 | $18.97 |
| Indicator | KIDS | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 62.83 | 62.42 |
| Support Level | $17.62 | $15.25 |
| Resistance Level | $19.15 | $15.71 |
| Average True Range (ATR) | 0.73 | 0.68 |
| MACD | 0.20 | 0.21 |
| Stochastic Oscillator | 100.00 | 95.38 |
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.